Piermont Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-14,919
Closed -$1.23M 254
2016
Q2
$1.23M Buy
14,919
+7,239
+94% +$596K 0.32% 116
2016
Q1
$583K Buy
7,680
+280
+4% +$20.7K 0.19% 130
2015
Q4
$595K Buy
7,400
+1,000
+16% +$72.1K 0.19% 125
2015
Q3
$407K Hold
6,400
0.13% 170
2015
Q2
$450K Buy
+6,400
New +$474K 0.14% 179
2015
Q1
Sell
-44,700
Closed -$2.85M 239
2014
Q4
$2.85M Sell
44,700
-570
-1% -$35.7K 1.01% 31
2014
Q3
$2.7M Sell
45,270
-3,670
-7% -$210K 1.05% 23
2014
Q2
$2.62M Buy
48,940
+7,740
+19% +$425K 1.02% 39
2014
Q1
$2.49M Buy
41,200
+920
+2% +$53.6K 1.2% 11
2013
Q4
$2.14M Buy
+40,280
New +$2.02M 1.07% 24

Other funds holding CRL